Protalix BioTherapeutics (PLX) FY 2025 Conference May 20, 2025 04:30 PM ET Speaker0 Is traded publicly under the ticker symbol PLX. My name is Ram Selvaraju, and I'm a Managing Director and Senior Healthcare Equity Research Analyst in Wainwright's Equity Research Division. We cover Protalix with a buy rating and twelve month price target of $10 per share. Presenting for the company will be Chief Financial Officer and Treasurer, Eyal Rubin. Eyal, it's a pleasure to have you with us. Thank you. Speaker1 Thank ...